Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

NCT ID: NCT05435625

Last Updated: 2022-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with Androgenetic alopecia will be randomized into 2 groups; Group FCO2 receiving Fractional CO2 or Group FRF receiving Fractional Microneedling Radiofrequency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Group FCO2 will be to receiving fractional CO2 to one randomized side of the scalp, and Group FRF will be receiving Fractional Microneedling radiofrequency to one randomized side of the scalp.

All patients will receive 4 sessions with 4-week intervals.each session will be followed by immediate topical application of 6 puffs (=1 mL) of minoxidil 5% solution twice daily and also in between the sessions and during follow up period

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Androgenic Alopecia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FCO2

Fractional Carbon dioxide laser

Group Type ACTIVE_COMPARATOR

FCO2

Intervention Type PROCEDURE

Fractional Carbon dioxide laser

FRF

Fractional Microneedling Radiofrequency

Group Type ACTIVE_COMPARATOR

FRF

Intervention Type PROCEDURE

Fractional Microneedling Radiofrequency

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FCO2

Fractional Carbon dioxide laser

Intervention Type PROCEDURE

FRF

Fractional Microneedling Radiofrequency

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • both genders are included.

* Patients above 18 years old.

Exclusion Criteria

* • Patients with patchy hair loss.

* Patients with Telogen Effluvium or diffuse alopecia areata.
* Patients with cicatricial alopecias.
* Patients with associated inflammatory scalp disorders such as psoriasis or seborrheic dermatitis.
* Patients with collagen vascular disorders.
* Prior use of topical steroids on scalp in the previous 2 weeks.
* Prior use of systemic steroids in the previous 1 month.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rana F Hilal, MD

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Al Ainy Hospital

Cairo, El Manial, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rana Hilal, MD

Role: CONTACT

2010014888

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rana Hilal, MD

Role: primary

1001488869

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Laser-RF:AGA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hydraderm for Androgenic Alopecia
NCT05426629 WITHDRAWN PHASE4